tirzepatide expected weight loss timeline weight-loss study shows promising results Tirzepatide for maintenance of bodyweight
Description
Tirzepatide is a dual-action medication that activates both GIP and GLP-1 receptors in your body
00656-2/asset/38c98550-9ec2-44e8-ba6a-dbb815075666/main.assets/gr1_lrg.jpg)
After initiation and dose increases, patients should be observed carefully for signs and symptoms of pancreatitis (including persistent severe abdominal pain, sometimes radiating to the back and which may or may not be accompanied by vomiting)
This means your licensed healthcare provider needs to submit documents that show you meet the eligibility criteria for Aetna coverage
,
For some patients, this can disrupt treatment continuity and lower adherence
During your first week, your body is getting used to Mounjaro
